These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 3987776

  • 21. How to calculate clearance of highly protein-bound drugs during continuous venovenous hemofiltration demonstrated with flucloxacillin.
    Meyer B, Ahmed el Gendy S, Delle Karth G, Locker GJ, Heinz G, Jaeger W, Thalhammer F.
    Kidney Blood Press Res; 2003; 26(2):135-40. PubMed ID: 12771540
    [Abstract] [Full Text] [Related]

  • 22. Flucloxacillin concentration in serum and wound exudate during open heart surgery.
    Farrington M, Fenn A, Phillips I.
    J Antimicrob Chemother; 1985 Aug; 16(2):253-9. PubMed ID: 3877718
    [Abstract] [Full Text] [Related]

  • 23. Protein binding of flucloxacillin in neonates.
    Pullen J, Stolk LM, Degraeuwe PL, van Tiel FH, Neef C, Zimmermann LJ.
    Ther Drug Monit; 2007 Jun; 29(3):279-83. PubMed ID: 17529883
    [Abstract] [Full Text] [Related]

  • 24. Bactericidal activity and pharmacology of flucloxacillin.
    Bergeron MG, Brusch JL, Barza M, Weinstein L.
    Am J Med Sci; 1976 Jun; 271(1):13-20. PubMed ID: 3969
    [Abstract] [Full Text] [Related]

  • 25. Concentrations of flucloxacillin in heart valves and subcutaneous and muscle tissues of patients undergoing open-heart surgery.
    Frank U, Schmidt-Eisenlohr E, Schlosser V, Spillner G, Schindler M, Daschner FD.
    Antimicrob Agents Chemother; 1988 Jun; 32(6):930-1. PubMed ID: 3415213
    [Abstract] [Full Text] [Related]

  • 26. Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics.
    Ulldemolins M, Roberts JA, Wallis SC, Rello J, Lipman J.
    J Antimicrob Chemother; 2010 Aug; 65(8):1771-8. PubMed ID: 20530507
    [Abstract] [Full Text] [Related]

  • 27. Total flucloxacillin plasma concentrations poorly reflect unbound concentrations in hospitalized patients with Staphylococcus aureus bacteraemia.
    Chin PKL, Drennan PG, Gardiner SJ, Zhang M, Dalton SC, Chambers ST, Begg EJ.
    Br J Clin Pharmacol; 2018 Oct; 84(10):2311-2316. PubMed ID: 29908071
    [Abstract] [Full Text] [Related]

  • 28. Low flucloxacillin concentrations in a patient with central nervous system infection: the need for plasma and cerebrospinal fluid drug monitoring in the ICU.
    Abdul-Aziz MH, McDonald C, McWhinney B, Ungerer JP, Lipman J, Roberts JA.
    Ann Pharmacother; 2014 Oct; 48(10):1380-4. PubMed ID: 24951308
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics of flucloxacillin and its metabolites in patients with renal failure: Impact on liver toxicity
.
    Maier-Salamon A, Elgendy SA, Meyer B, Vossen M, Thalhammer T, Thalhammer F, Jäger W.
    Int J Clin Pharmacol Ther; 2017 Sep; 55(9):701-711. PubMed ID: 28737131
    [Abstract] [Full Text] [Related]

  • 30. The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis.
    Leder K, Turnidge JD, Korman TM, Grayson ML.
    J Antimicrob Chemother; 1999 Jan; 43(1):113-8. PubMed ID: 10381108
    [Abstract] [Full Text] [Related]

  • 31. Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin.
    Landersdorfer CB, Kirkpatrick CM, Kinzig-Schippers M, Bulitta JB, Holzgrabe U, Drusano GL, Sörgel F.
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3290-7. PubMed ID: 17576847
    [Abstract] [Full Text] [Related]

  • 32. The binding of isoxazolyl penicillins to human serum proteins.
    Ulmann U.
    Arzneimittelforschung; 1977 Sep; 27(11):2136-8. PubMed ID: 580016
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of flucloxacillin tubular renal secretion by piperacillin.
    Landersdorfer CB, Kirkpatrick CM, Kinzig M, Bulitta JB, Holzgrabe U, Sörgel F.
    Br J Clin Pharmacol; 2008 Nov; 66(5):648-59. PubMed ID: 19032173
    [Abstract] [Full Text] [Related]

  • 34. Plasma concentration following oral administration of di- and flucloxacillin in infants and children.
    Bergdahl S, Eriksson M, Finkel Y.
    Pharmacol Toxicol; 1987 Mar; 60(3):233-4. PubMed ID: 3588519
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of intravenous flucloxacillin and amoxicillin in neonatal and infant cardiopulmonary bypass surgery.
    Adrianzén Vargas MR, Danton MH, Javaid SM, Gray J, Tobin C, Brawn WJ, Barron DJ.
    Eur J Cardiothorac Surg; 2004 Feb; 25(2):256-60. PubMed ID: 14747123
    [Abstract] [Full Text] [Related]

  • 36. Dicloxacillin and flucloxacillin twice daily with probenecid in staphylococcal infections. A clinical and pharmakokinetic evaluation.
    Hedström SA, Kahlmeter G.
    Scand J Infect Dis; 1980 Feb; 12(3):221-5. PubMed ID: 7433922
    [Abstract] [Full Text] [Related]

  • 37. Oral absorption of flucloxacillin in infants and young children.
    Bergdahl S, Eriksson M, Finkel Y, Lännergren K.
    Acta Pharmacol Toxicol (Copenh); 1986 Apr; 58(4):255-8. PubMed ID: 3716820
    [Abstract] [Full Text] [Related]

  • 38. Population pharmacokinetic modelling of total and unbound flucloxacillin in non-critically ill patients to devise a rational continuous dosing regimen.
    Wilkes S, van Berlo I, Ten Oever J, Jansman F, Ter Heine R.
    Int J Antimicrob Agents; 2019 Mar; 53(3):310-317. PubMed ID: 30472288
    [Abstract] [Full Text] [Related]

  • 39. Concentrations of cloxacillin, dicloxacillin and flucloxacillin in dental alveolar serum and mandibular bone.
    Köndell PA, Nord CE, Nordenram A.
    Int J Oral Surg; 1982 Feb; 11(1):40-3. PubMed ID: 6811456
    [Abstract] [Full Text] [Related]

  • 40. [Flucloxacillin].
    Mastroviti S, Cassarino G.
    G Batteriol Virol Immunol; 1975 Feb; 68(7-12):279-88. PubMed ID: 1234594
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.